Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours
Clinical trial NCT05199753 · COMPLETED
Trial details
- NCT number
- NCT05199753
- Sponsor
- LaNova Australia Pty Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-16
- Primary completion
- 2024-12-31
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.